a 24.57 percent reduction For the 1st quarter of 2020, This showed an improvement from last year when consolidated loss was 16.11 million bath and 12.46 million bath for separate financial statements
% comparing to the same period last year, this is caused by followings: Consolidated financial statements Revenues 1. Total revenues from hire of work of 3.68 Million Baht was 1.44 Million Baht or 64.02
Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the 1st quarter ended March 31, 2018. The details are as
Consolidated ∆% Separate ∆% Q1/2018 Q1/2017 Q1/2018 Q1/2017 Revenues from sales and services 529,514 669,009 -21% 320,648 445,078 -28% Interest income 121 363 -67% 121 8,930 -99% Gain on disposal of assets
) Consolidated Financial Statements Separate Financial Statements 2Q20 2Q19 Change 2Q20 2Q19 Change Revenues from hospital operations 116.75 213.42 -45.30% 114.01 163.39 -30.22% Cost of hospital operations 96.62
as follows. The total revenue of the Company and its subsidiaries in the consolidated financial statements for the year 2017 was equal to 762.85 million Baht, an increase of 148.67 million Baht or
as related to Cannabiz way Co., Ltd and CBD Bioscience Co., Ltd that would impact on the consolidated financial statements and the separate financial statements. Therefore, the SEC has notified EE (1
Company”) would like to submit the Management Discussion and Analysis of the Company’s operation for the three-month period ended 30 June, 2020 with details as follows: Unit: Million Baht Consolidated
Consolidated assets (THB) Consolidated income (THB) Consolidated net profit (loss) (THB) Separate assets (THB) Separate income (THB) Separate net profit (loss) (THB) Audit fee (THB) Other fees Auditor’s opinions